Recombinant CELA3B / ELA3B (Pancreatic Function Marker) Antibody [CELA3B/1759R]

In Stock
Catalog Number Formulation Size Price
23436-RBM9-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$259.00
23436-RBM9-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$559.00
23436-RBM9-P1ABX
Purified Ab WITHOUT BSA or Azide at 1.0mg/ml
100ug
$559.00
Flat Rate Domestic: $95 | Orders outside the US - Contact Us for Order Information | Ships next business day

Applications & Dilutions

Applications Tested Dillution Protocol Note
Immunohistochemistry (IHC)
1-2ug/ml
30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes
Western Blot (WB)
2-4ug/ml

Summary

Efficient protease with alanine specificity but only little elastolytic activity.

Product Properties & Targets

Host
Rabbit
Species Reactivity
Isotype / Light Chain
IgG / Kappa
Gene Name
Positive Control
Pancreas
Immunogen
Recombinant fragment (around aa82-238) of the human CELA3B protein (exact sequence is proprietary)
Alternate Names
Chymotrypsin-like elastase family member 3B, CBPP|ELA3B

Database Links

Entrez Gene ID
SwissProt

Additional Information

Clone
CELA3B/1759R
Chromosome Location
1p36.12
Mol. Weight of Antigen
29.26kDa
Expression System
HEK293 Cells
Purification
Protein A

Functions

  • Efficient protease with alanine specificity but only little elastolytic activity.

Storage & Stability

Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab produced in a mammalian-based expression system. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK